Your browser doesn't support javascript.
loading
Prevalence of drug-resistant tuberculosis and imputed burden in South Africa: a national and sub-national cross-sectional survey.
Ismail, Nazir Ahmed; Mvusi, Lindiwe; Nanoo, Ananta; Dreyer, Andries; Omar, Shaheed V; Babatunde, Sanni; Molebatsi, Thabo; van der Walt, Martie; Adelekan, Adeboye; Deyde, Varough; Ihekweazu, Chikwe; Madhi, Shabir A.
Afiliação
  • Ismail NA; National Institute for Communicable Diseases, Johannesburg, South Africa; Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa. Electronic address: nazir.ismail@gmail.com.
  • Mvusi L; National Department of Health, Tuberculosis Cluster, Pretoria, South Africa.
  • Nanoo A; National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Dreyer A; National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Omar SV; National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Babatunde S; World Health Organization-South Africa Mission, Pretoria, South Africa.
  • Molebatsi T; National Department of Health, Tuberculosis Cluster, Pretoria, South Africa.
  • van der Walt M; Medical Research Council, Tuberculosis Platform, Pretoria, South Africa.
  • Adelekan A; Centers for Disease Control and Prevention South Africa, Pretoria, South Africa.
  • Deyde V; Centers for Disease Control and Prevention South Africa, Pretoria, South Africa.
  • Ihekweazu C; National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Madhi SA; National Institute for Communicable Diseases, Johannesburg, South Africa; Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa; Department of Science/National Research Foundation: Vaccine Prev
Lancet Infect Dis ; 18(7): 779-787, 2018 07.
Article em En | MEDLINE | ID: mdl-29685458
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazinamida / Tuberculose Resistente a Múltiplos Medicamentos / Tuberculose Extensivamente Resistente a Medicamentos / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: Lancet Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazinamida / Tuberculose Resistente a Múltiplos Medicamentos / Tuberculose Extensivamente Resistente a Medicamentos / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: Lancet Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2018 Tipo de documento: Article